Physician-scientists at the Johns Hopkins Kimmel Cancer Center are helping set the standard of care for breast cancer therapies, says Dr. Vered Stearns, co-director of the Breast Cancer Program. Clinicians are always researching new therapies or new combinations of existing therapies to maximize each patient’s response to treatment.
“We are embarking on a new era of cancer management as treatment is becoming more tailored to the individual patient’s genetic makeup,” says Dr. Stearns, an internationally recognized breast cancer researcher. Dr. Stearns’ work using biomarkers to guide breast cancer prevention and treatment strategies, and deciphering genetically determined variations in patients’ responses to the breast cancer drug tamoxifen, has earned widespread recognition. Her work also led to improved therapeutic options for women suffering from hot flashes.
Learn more about: